Page last updated: 2024-09-02

3',4'-dichlorobenzamil and Bone Loss, Osteoclastic

3',4'-dichlorobenzamil has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, SG; Krieger, NS1

Other Studies

1 other study(ies) available for 3',4'-dichlorobenzamil and Bone Loss, Osteoclastic

ArticleYear
Dichlorobenzamil inhibits stimulated bone resorption in vitro.
    Endocrinology, 1988, Volume: 122, Issue:2

    Topics: Amiloride; Animals; Bone Resorption; Calcitriol; Calcium; Cells, Cultured; Dinoprostone; Diuretics; In Vitro Techniques; Mice; Parathyroid Hormone; Prostaglandins E; Protein Biosynthesis; Time Factors

1988